Shepherd Kaplan Krochuk’s Charles River Laboratories CRL Stock Holding History

Shepherd Kaplan Krochuk’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-3,082	Closed	-$248K	–	301
2015 Q4	$248K	Buy	+3,082	New	+$222K	0.07%	226
2015 Q1	–	Sell	-3,588	Closed	-$228K	–	418
2014 Q4	$228K	Hold	3,588	–	–	0.04%	320
2014 Q3	$214K	Buy	+3,588	New	+$205K	0.03%	426
2014 Q2	–	Sell	-3,588	Closed	-$216K	–	576
2014 Q1	$216K	Sell	3,588 -3,412	-49%	-$199K	0.02%	437
2013 Q4	$371K	Hold	7,000	–	–	0.05%	260
2013 Q3	$323K	Hold	7,000	–	–	0.05%	271
2013 Q2	$287K	Buy	+7,000	New	+$300K	0.06%	299

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Shepherd Kaplan Krochuk's CRL Position: Q1 2016 in Review

Shepherd Kaplan Krochuk sold out of Charles River Laboratories (CRL) in Q1 2016, closing a stake of 3,082 shares — an estimated $248K sold.

Shepherd Kaplan Krochuk first reported a position in CRL in Q2 2013 and held it in 7 quarters. The position peaked at $371K in Q4 2013. 264 funds tracked by Wall St. Rank hold CRL as of Q1 2016.

Shepherd Kaplan Krochuk reported no remaining Charles River Laboratories position as of Q1 2016 after selling out during the quarter.
Shepherd Kaplan Krochuk sold 3,082 Charles River Laboratories shares in Q1 2016, an estimated $248K.
Shepherd Kaplan Krochuk first reported a position in Charles River Laboratories in Q2 2013 and held it in 7 quarters.
Shepherd Kaplan Krochuk's Charles River Laboratories position peaked at $371K in Q4 2013.
264 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2016.

Based on Shepherd Kaplan Krochuk's 13F filing for Q1 2016, filed 16 May 2016.